MedPage Today on MSN
Phone Data May Give Early Warning on Rheumatoid Arthritis Flares
Rheumatoid arthritis patients often don't notice disease flares until symptoms have already worsened substantially. As joint ...
GlobalData on MSN
Lynk’s selective JAK inhibitor claims Phase III RA win
Lynk’s zemprocitinib commercial partner, Simcere, will now continue the JAK inhibitor’s development across China in RA.
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
MedPage Today on MSN
Not All Drugs Approved for Rheumatoid Arthritis Are Equal for Pain Relief
Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...
Nearly 1.5 million Americans and nearly 5% of women over the age of 55 have rheumatoid arthritis (RA), an incurable ...
A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 inhibitor in China has hit its primary endpoint, boosting ...
Exposure to occupational inhalants such as silica, pesticides, asbestos, solvents, fertilizers, animal dust and engine ...
While the exact cause of rheumatoid arthritis is unknown, genetics play a significant role, with the HLA-DR4 gene increasing the risk. However, most people with RA are the only ones in their family ...
Rheumatoid arthritis often involves your wrists, knees, and feet. But it can also affect your spine. Most of the time, this kind of back pain responds well to arthritis treatments such as biologics.
Most people with rheumatoid arthritis have tender, swollen joints, but there are other symptoms you may not be as familiar with, such as hearing problems, trouble sleeping, and others. When you think ...
Rheumatoid arthritis (RA) is one of the most common autoimmune diseases. It happens when your body makes antibodies that attack synovial joint fluid and cause long-term inflammation as well as damage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results